Double Trouble? CMC with a Mutation in both AIRE and STAT1

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann N Y Acad Sci. 2011;1246:77–91.

    Article  PubMed  CAS  Google Scholar 

  2. 2.

    Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, et al. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 2015;42(6):1185–96.

    Article  PubMed  CAS  Google Scholar 

  3. 3.

    Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635–48.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. 4.

    van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LAB, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54–61.

    Article  PubMed  Google Scholar 

  5. 5.

    Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154–64.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. 6.

    Sobh A, Chou J, Schneider L, Geha RS, Massaad MJ. Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation. J Allergy Clin Immunol. 2016;138(1):297–9.

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Meesilpavikkai K, Dik WA, Schrijver B, et al. A novel heterozygous mutation in the STAT1 SH2 domain causes chronic mucocutaneous candidiasis, atypically diverse infections, autoimmunity, and impaired cytokine regulation. Front Immunol. 2017;8:274.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. 8.

    Higgins E, Al Shehri T, McAleer MA, et al. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. J Allergy Clin Immunol. 2015;135(2):551–3.

    Article  PubMed  CAS  Google Scholar 

Download references


We wish to thank our patient and his parents for their permission to publish this case.

Author information



Corresponding author

Correspondence to Timothy Ronan Leahy.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic supplementary material


(DOCX 282 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Al Dhanhani, H., Al Shehri, T., Lilic, D. et al. Double Trouble? CMC with a Mutation in both AIRE and STAT1. J Clin Immunol 38, 635–637 (2018).

Download citation